568 related articles for article (PubMed ID: 24667415)
21. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
23. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
24. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
25. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1
Sengupta-Ghosh A; Dominguez SL; Xie L; Barck KH; Jiang Z; Earr T; Imperio J; Phu L; Budayeva HG; Kirkpatrick DS; Cai H; Eastham-Anderson J; Ngu H; Foreman O; Hedehus M; Reichelt M; Hotzel I; Shang Y; Carano RAD; Ayalon G; Easton A
Neurobiol Dis; 2019 Apr; 124():340-352. PubMed ID: 30528255
[TBL] [Abstract][Full Text] [Related]
26. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.
Jokic N; Gonzalez de Aguilar JL; Dimou L; Lin S; Fergani A; Ruegg MA; Schwab ME; Dupuis L; Loeffler JP
EMBO Rep; 2006 Nov; 7(11):1162-7. PubMed ID: 17039253
[TBL] [Abstract][Full Text] [Related]
27. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
[TBL] [Abstract][Full Text] [Related]
28. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS.
Dong QX; Zhu J; Liu SY; Yu XL; Liu RT
Int Immunopharmacol; 2018 Dec; 65():413-421. PubMed ID: 30388515
[TBL] [Abstract][Full Text] [Related]
29. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
30. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.
Acevedo-Arozena A; Kalmar B; Essa S; Ricketts T; Joyce P; Kent R; Rowe C; Parker A; Gray A; Hafezparast M; Thorpe JR; Greensmith L; Fisher EM
Dis Model Mech; 2011 Sep; 4(5):686-700. PubMed ID: 21540242
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
Bette M; Cors E; Kresse C; Schütz B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328829
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
Liu X; Zhang J; Li J; Song C; Shi Y
Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
[TBL] [Abstract][Full Text] [Related]
34. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
35. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
36. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
38. Caspase 6 has a protective role in SOD1(G93A) transgenic mice.
Hogg MC; Mitchem MR; König HG; Prehn JH
Biochim Biophys Acta; 2016 Jun; 1862(6):1063-73. PubMed ID: 26976329
[TBL] [Abstract][Full Text] [Related]
39. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
40. Distinct roles for motor neuron autophagy early and late in the SOD1
Rudnick ND; Griffey CJ; Guarnieri P; Gerbino V; Wang X; Piersaint JA; Tapia JC; Rich MM; Maniatis T
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8294-E8303. PubMed ID: 28904095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
